For the last two decades, pathogenic concepts in Parkinson disease (PD) have revolved
around the toxicity and spread of α-synuclein. Thus, α-synuclein would follow caudo-rostral …

Cognitive impairment is increasingly recognized to be a core feature of multiple sclerosis
(MS), with important implications for the everyday life of individuals with MS and for disease …

Changes in gene expression that occur across the central nervous system (CNS) during
neurological diseases do not address the heterogeneity of cell types from one CNS region to …

Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing neuroinflammatory
autoimmune astrocytopathy, with a predilection for the optic nerves and spinal cord. Most …

Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system that is
characterised by inflammatory damage to the myelin sheath. Though often neglected …

Cognitive impairment has been reported at all phases and all subtypes of multiple sclerosis.
It remains a major cause of neurological disability in young and middle-aged adults suffering …

Background: Cognitive postscripts of COVID-19, codenamed as 'cognitive COVID'or 'brain
fog,'characterized by multidomain cognitive impairments, are now being reckoned as the …

Introduction Multiple Sclerosis (MS) is a chronic neurodegenerative disorder that affects the
central nervous system (CNS) and results in progressive clinical disability and cognitive …

Cognitive impairment (CI) is a disabling concomitant of multiple sclerosis (MS) with a
complex and controversial pathogenesis. The cytokine interleukin-17A (IL-17A) is involved …

Synapses are well known as the main structures responsible for transmitting information
through the release and recognition of neurotransmitters by pre-and post-synaptic neurons …